Literature DB >> 29467354

High Signal Intensity on T2-Weighted Cardiovascular Magnetic Resonance Imaging Predicts Life-Threatening Arrhythmic Events in Hypertrophic Cardiomyopathy Patients.

Yasuki Hen1, Ayako Takara1, Nobuo Iguchi1, Yuko Utanohara1, Kunihiko Teraoka1, Kaori Takada2, Haruhiko Machida3, Itaru Takamisawa1, Morimasa Takayama1, Tsutomu Yoshikawa1.   

Abstract

BACKGROUND: The prognostic value of high signal intensity on T2-weighted cardiovascular magnetic resonance imaging (T2 high signal) in hypertrophic cardiomyopathy (HCM) patients in a single-center cohort was investigated.Methods and 
Results: A total of 237 HCM patients (median age, 62 years; 143 male) underwent T2-weighted, cine and late gadolinium enhancement (LGE) imaging, and were followed (median duration, 3.4 years) for life-threatening arrhythmic events. The clinical and magnetic resonance imaging characteristics were extracted, and predictors of life-threatening arrhythmic events were assessed on multivariate analysis. LGE was present in 180 patients (75.9%). Median LGE score was 3 in a left ventricle 17-segment model. T2 high signal was present in 49 patients (20.7%). The annual events rate was significantly higher in patients with extensive LGE (score ≥4) than in those without (3.0%/year vs. 0.5%/year, P=0.011). On multivariate analysis, extensive LGE (hazard ratio, 5.650; 95% CI: 1.263-25.000, P=0.024) as an independent predictor for life-threatening arrhythmic events. In patients with extensive LGE, the annual events rate was significantly higher in patients with T2 high signal than in those without (5.8%/year vs. 0.9%/year, P=0.008).
CONCLUSIONS: Extensive LGE was an independent predictor of life-threatening arrhythmic events in HCM patients. Furthermore, T2 high signal is useful for the risk stratification of serious arrhythmic events in patients with extensive LGE.

Entities:  

Keywords:  Cardiac magnetic resonance; Hypertrophic cardiomyopathy; Late gadolinium enhancement; Life-threatening arrhythmic event; T2-weighted imaging

Mesh:

Substances:

Year:  2018        PMID: 29467354     DOI: 10.1253/circj.CJ-17-1235

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  8 in total

Review 1.  Society for Cardiovascular Magnetic Resonance/European Society of Cardiovascular Imaging/American Society of Echocardiography/Society for Pediatric Radiology/North American Society for Cardiovascular Imaging Guidelines for the Use of Cardiac Magnetic Resonance in Pediatric Congenital and Acquired Heart Disease: Endorsed by The American Heart Association.

Authors:  Mark A Fogel; Shaftkat Anwar; Craig Broberg; Lorna Browne; Taylor Chung; Tiffanie Johnson; Vivek Muthurangu; Michael Taylor; Emanuela Valsangiacomo-Buechel; Carolyn Wilhelm
Journal:  Circ Cardiovasc Imaging       Date:  2022-06-21       Impact factor: 8.589

Review 2.  Society for Cardiovascular Magnetic Resonance/European Society of Cardiovascular Imaging/American Society of Echocardiography/Society for Pediatric Radiology/North American Society for Cardiovascular Imaging Guidelines for the use of cardiovascular magnetic resonance in pediatric congenital and acquired heart disease : Endorsed by The American Heart Association.

Authors:  Mark A Fogel; Shaftkat Anwar; Craig Broberg; Lorna Browne; Taylor Chung; Tiffanie Johnson; Vivek Muthurangu; Michael Taylor; Emanuela Valsangiacomo-Buechel; Carolyn Wilhelm
Journal:  J Cardiovasc Magn Reson       Date:  2022-06-21       Impact factor: 6.903

Review 3.  Clinical application of CMR in cardiomyopathies: evolving concepts and techniques : A position paper of myocardial and pericardial diseases and cardiac magnetic resonance working groups of Italian society of cardiology.

Authors:  Marco Merlo; Giulia Gagno; Anna Baritussio; Barbara Bauce; Elena Biagini; Marco Canepa; Alberto Cipriani; Silvia Castelletti; Santo Dellegrottaglie; Andrea Igoren Guaricci; Massimo Imazio; Giuseppe Limongelli; Maria Beatrice Musumeci; Vanda Parisi; Silvia Pica; Gianluca Pontone; Giancarlo Todiere; Camilla Torlasco; Cristina Basso; Gianfranco Sinagra; Pasquale Perrone Filardi; Ciro Indolfi; Camillo Autore; Andrea Barison
Journal:  Heart Fail Rev       Date:  2022-05-10       Impact factor: 4.654

4.  Texture analysis of T2-weighted cardiovascular magnetic resonance imaging to discriminate between cardiac amyloidosis and hypertrophic cardiomyopathy.

Authors:  Yuan Li; Zhi-Gang Yang; Shan Huang; Ke Shi; Yi Zhang; Wei-Feng Yan; Ying-Kun Guo
Journal:  BMC Cardiovasc Disord       Date:  2022-05-21       Impact factor: 2.174

5.  High T2-weighted signal intensity is associated with myocardial deformation in hypertrophic cardiomyopathy.

Authors:  Ruo-Yang Shi; Dong-Aolei An; Bing-Hua Chen; Rui Wu; Chong-Wen Wu; Liang Du; Jiong Zhu; Meng Jiang; Jian-Rong Xu; Lian-Ming Wu
Journal:  Sci Rep       Date:  2019-02-25       Impact factor: 4.379

6.  Endogenous T1ρ cardiovascular magnetic resonance in hypertrophic cardiomyopathy.

Authors:  Elizabeth W Thompson; Srikant Kamesh Iyer; Michael P Solomon; Zhaohuan Li; Qiang Zhang; Stefan Piechnik; Konrad Werys; Sophia Swago; Brianna F Moon; Zachary B Rodgers; Anya Hall; Rishabh Kumar; Nosheen Reza; Jessica Kim; Alisha Jamil; Benoit Desjardins; Harold Litt; Anjali Owens; Walter R T Witschey; Yuchi Han
Journal:  J Cardiovasc Magn Reson       Date:  2021-10-25       Impact factor: 5.364

7.  T2-weighted cardiac magnetic resonance image and myocardial biomarker in hypertrophic cardiomyopathy.

Authors:  Shi Chen; Liwei Huang; Qing Zhang; Jie Wang; Yucheng Chen
Journal:  Medicine (Baltimore)       Date:  2020-06-05       Impact factor: 1.817

8.  Cardiovascular magnetic resonance T2* mapping for the assessment of cardiovascular events in hypertrophic cardiomyopathy.

Authors:  Mareike Gastl; Christiane Gruner; Karin Labucay; Alexander Gotschy; Jochen Von Spiczak; Malgorzata Polacin; Florian Boenner; Malte Kelm; Frank Ruschitzka; Hatem Alkadhi; Sebastian Kozerke; Robert Manka
Journal:  Open Heart       Date:  2020-03-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.